D017321Activities & BehaviorsProceduresE05.318.760.250.500.200N05.715.360.775.088.500.200N06.850.520.450.250.250.200660.995827Clinical Trials, Phase I as Topicplugins:TwitterTwitterFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.3306270.0258856research area of0.3320120.06475787subject area forEmergency MedicinePediatricsRadiation OncologyRush University, College of Health SciencesMindySimpsonMindy Simpson349108Simpson, MindyAssistant ProfessorGeorgeFitchettGeorge Fitchett349272Fitchett, GeorgeProfessorRossAbramsRoss Abrams349600Abrams, RossProfessorJohnSombergJohn Somberg349673Somberg, JohnProfessor6Assistant Professor5Associate Professor4Professor15386780Daugherty CK, Fitchett G, Murphy PE, Peterman AH, Banik DM, Hlubocky F, Tartaro JPsycho-oncologyTrusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psychooncology. 2005 Feb; 14(2):135-46.Psychooncology2005-02-01T00:00:002005Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents.18496258Nada A, Baxter S, Loraas E, Somberg JCAmerican journal of therapeuticsIncidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States. Am J Ther. 2008 May-Jun; 15(3):214-20.Am J Ther2008-05-01T00:00:002008Incidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States.21633289Pederson AW, Salama JK, Witt ME, Stenson KM, Blair EA, Vokes EE, Haraf DJAmerican journal of clinical oncologyConcurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol. 2011 Aug; 34(4):356-61.Am J Clin Oncol2011-08-01T00:00:002011Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.33296943Mancuso ME, Reding MT, Negrier C, Kerlin BA, Rangarajan S, Simpson MLThrombosis and haemostasisDecreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis. Thromb Haemost. 2021 08; 121(8):1079-1086.Thromb Haemost2020-12-09T00:00:002020Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis.Rush University, Rush Medical CollegeMichaelGottliebMichael A. Gottlieb349900Gottlieb, Michael0000-0003-3276-8375Associate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorReligion Health and Human Valuestrue1ProfessorProfessorInternal Medicine, Division of Cardiologytrue1Associate ProfessorAssociate Professor28110992Gottlieb M, Khishfe BAnnals of emergency medicineIdarucizumab for the Reversal of Dabigatran. Ann Emerg Med. 2017 May; 69(5):554-558.Ann Emerg Med2017-01-19T00:00:002017Idarucizumab for the Reversal of Dabigatran.true1ProfessorProfessorTwitter @MGottliebMDhttps://www.rushu.rush.edu/faculty/michael-gottlieb-mdRush Faculty Profilehttps://www.ncbi.nlm.nih.gov/myncbi/1nE9coTcjp0kx/bibliography/public/NCBI Bibliographyhttps://scholar.google.com/citations?user=c-1ZE4wAAAAJ&hl=enGoogle Scholarhttps://www.scopus.com/authid/detail.uri?authorId=56089778500Scopushttp://orcid.org/0000-0003-3276-8375ORCID